{
    "organizations": [],
    "uuid": "218c8424e9d5857ff8f0849a5a378e85fa3fdaf2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-galectin-therapeutics-provides-bus/brief-galectin-therapeutics-provides-business-update-idUSASC09U75",
    "ord_in_thread": 0,
    "title": "Galectin Therapeutics Provides Business Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Galectin Therapeutics Inc:\n* GALECTIN THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* GALECTIN THERAPEUTICS - BELIEVES HAS SUFFICIENT CASH TO FUND CURRENTLY PLANNED OPERATIONS & RESEARCH & DEVELOPMENT ACTIVITIES THROUGH AT LEAST MARCH 31, 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T20:12:00.000+03:00",
    "crawled": "2018-03-30T12:59:36.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "galectin",
        "therapeutic",
        "inc",
        "galectin",
        "therapeutic",
        "report",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "galectin",
        "therapeutic",
        "belief",
        "sufficient",
        "cash",
        "fund",
        "currently",
        "planned",
        "operation",
        "research",
        "development",
        "activity",
        "least",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}